Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberis aristata root versus metformin in type 2 diabetes mellitus
IRCT201207191774N5Phase 3Completed
- Sponsor
- Physiology Research Center, Kerman University of Medical Sciences
- Start
- Dec 2013
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of berberis aristata and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Physiology Research Center, Kerman University of Medical Sciences. Started Dec 2013; status: completed.
02
Drugs
berberis aristatametformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201207191774N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201207191774N5.